Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment. Blas L, Shiota M, Matsumoto T, Hori Y, et al. Int J Urol 2023;30:1029-1034.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blas L, Shiota M, Matsumoto T, Hori Y, et al. Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment. Int J Urol 2023;30:1029-1034.
PMID: 37501328